Hospira Buprenorphine Hydrochloride Injection and Labetalol Hydrochloride Injection - recalled due to Packaging Defect, USA
3 weeks ago •source fda.gov • details
Recall notice
Hospira, Inc., a Pfizer company (“Pfizer”), is voluntarily recalling the lots listed in the table below of Buprenorphine Hydrochloride Injection CarpujectTM Units and Labetalol Hydrochloride Injection, USP CarpujectTM Units to the User level. The recall was initiated due to the potential for incomplete crimp seals; one customer…
321
